BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30179535)

  • 1. Sweet flowers are slow, and weeds make haste: leveraging methodology from research on tobacco, alcohol, and opioid analgesics to make rapid and policy-relevant advances in cannabis science.
    Herrmann ES; Jarvis BP; Sparks AC; Cohn AM; Koszowski B; Rosenberry ZR; Coleman-Cowger VH; Pickworth WB; Peters EN
    Int Rev Psychiatry; 2018 Jun; 30(3):238-250. PubMed ID: 30179535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six policy lessons relevant to cannabis legalization.
    Shover CL; Humphreys K
    Am J Drug Alcohol Abuse; 2019; 45(6):698-706. PubMed ID: 30870053
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-medical cannabis in North America: an overview of regulatory approaches.
    Lancione S; Wade K; Windle SB; Filion KB; Thombs BD; Eisenberg MJ
    Public Health; 2020 Jan; 178():7-14. PubMed ID: 31600630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential impact of cannabis legalization on the development of cannabis use disorders.
    Budney AJ; Borodovsky JT
    Prev Med; 2017 Nov; 104():31-36. PubMed ID: 28668544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public Health and Medicine's Need to Respond to Cannabis Commercialization in the United States: A Commentary.
    Bowling CM; Hafez AY; Glantz SA
    J Psychoactive Drugs; 2020; 52(4):377-382. PubMed ID: 32429772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy designs for cannabis legalization: starting with the eight Ps.
    Kilmer B
    Am J Drug Alcohol Abuse; 2014 Jul; 40(4):259-61. PubMed ID: 24853283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critique of cannabis legalization proposals in Canada.
    Kalant H
    Int J Drug Policy; 2016 Aug; 34():5-10. PubMed ID: 27292414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common public health-oriented policy framework for cannabis, alcohol and tobacco in Canada?
    Kirst M; Kolar K; Chaiton M; Schwartz R; Emerson B; Hyshka E; Jesseman R; Lucas P; Solomon R; Thomas G
    Can J Public Health; 2016 Mar; 106(8):e474-6. PubMed ID: 26986906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging prospects for non-medical cannabis legalisation in New Zealand: An initial view and contextualization.
    Fischer B; Bullen C
    Int J Drug Policy; 2020 Feb; 76():102632. PubMed ID: 31864106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the public health impacts of legalizing recreational cannabis use in the USA.
    Hall W; Weier M
    Clin Pharmacol Ther; 2015 Jun; 97(6):607-15. PubMed ID: 25777798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis, pesticides and conflicting laws: the dilemma for legalized States and implications for public health.
    Stone D
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):284-8. PubMed ID: 24859075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018.
    Cox C
    Health Policy; 2018 Mar; 122(3):205-209. PubMed ID: 29429644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-Stage Cannabis Regulatory Policy Planning Across Canada's Four Largest Provinces: A Descriptive Overview.
    Watson TM; Hyshka E; Bonato S; Rueda S
    Subst Use Misuse; 2019; 54(10):1691-1704. PubMed ID: 31076006
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale for cannabis-based interventions in the opioid overdose crisis.
    Lucas P
    Harm Reduct J; 2017 Aug; 14(1):58. PubMed ID: 28821296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis legalization, regulation, & control: a review of key challenges for local, state, and provincial officials.
    Caulkins JP; Kilborn ML
    Am J Drug Alcohol Abuse; 2019; 45(6):689-697. PubMed ID: 31135218
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating the public health impacts of legalizing recreational cannabis use in the United States.
    Hall W; Lynskey M
    Addiction; 2016 Oct; 111(10):1764-73. PubMed ID: 27082374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis policy reforms in the Americas: a comparative analysis of Colorado, Washington, and Uruguay.
    Pardo B
    Int J Drug Policy; 2014 Jul; 25(4):727-35. PubMed ID: 24970383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Le marché légal du cannabis suite à sa légalisation au Canada : pistes de réflexion pour un encadrement efficace.
    Patenaude C; Brochu S; Fallu JS; Jutras-Aswad D; D'Arcy L
    Can J Public Health; 2018 Apr; 109(2):215-218. PubMed ID: 29981041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and Health Research: Rapid Progress Requires Innovative Research Designs.
    Hutchison KE; Bidwell LC; Ellingson JM; Bryan AD
    Value Health; 2019 Nov; 22(11):1289-1294. PubMed ID: 31708066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis regulatory science: risk-benefit considerations for mental disorders.
    Borodovsky JT; Budney AJ
    Int Rev Psychiatry; 2018 Jun; 30(3):183-202. PubMed ID: 29843548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.